4D Molecular Therapeutics Inc
NASDAQ:FDMT 4:00:00 PM EDT
Market Cap (Intraday) | 1.59B |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $32.81 |
50-Day MA | $26.85 |
200-Day MA | $18.46 |
4D Molecular Therapeutics Inc Stock, NASDAQ:FDMT
5858 Horton Street, Suite 455, Emeryville, California 94608
United States of America
Phone: +1.510.505.2680
Number of Employees: 147
Description
4D Molecular Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of unlocking the full potential of genetic medicines to treat large market diseases in ophthalmology and pulmonology. The firm also offers product candidates focused on large market ophthalmology, pulmonology, and cardiology. The company was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.